DNA microarray screening of differential gene expression in bone marrow samples from AML, non-AML patients and AML cell lines

Leukemia Research

Volumn 28, Issue 7, 2004, Pages 743-753

  Court, Emma Louise ^a   Smith, M Ann ^a   Avent, Neil David ^a   Hancock, John T ^a   Morgan, Lyn M ^b   Gray, Atherton G ^c   Smith, J Graham ^a  

^a UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^b ROYAL UNITED HOSPITAL   (United Kingdom)

^c GREAT WESTERN HOSPITAL   (United Kingdom)

Author keywords

Acute myeloblastic leukaemia (AML); c myc; cDNA microarrays; Glutathione S transferase pi (GSTP); High mobility group protein (HMG 1); Migration inhibitory factor related protein (MRP 8 and MRP 14)

Indexed keywords

CALGRANULIN; COMPLEMENTARY DNA; GENE PRODUCT; GLUTATHIONE TRANSFERASE; HIGH MOBILITY GROUP B1 PROTEIN; MYC PROTEIN;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; BONE MARROW; CANCER CHEMOTHERAPY; CANCER PATIENT; CELL DIFFERENTIATION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA MICROARRAY; DNA TRANSCRIPTION; DOT HYBRIDIZATION; GENE EXPRESSION; GENETIC CODE; GENETIC SCREENING; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SAMPLING; UPREGULATION;

ADULT; AGED; BIOPSY; BONE MARROW; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE TRANSFERASE; HMGB1 PROTEIN; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-MYC; UP-REGULATION;

EID: 2442517390     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2003.11.011     Document Type: Article

References (56)

1. Reilly J.T., Bain B.J., England J.M., Hyde K., Matutes E., Murphy M., et al. The role of cytology, cytochemistry, immunophenotyping and cytogenetic analysis in the diagnosis of haematological neoplasms. Clin. Lab. Haem. 18:1996;231-236
2. Buchner T. Treatment of acute myeloid leukemia. Curr. Opin. Haematol. 1:1993;50-61
3. Walker J., Flower D., Rigley K. Microarrays in hematology. Curr. Opin. Hematol. 9:2002;23-29
4. Davis R.E., Staudt L.M. Molecular diagnosis of lymphoid malignancies by gene expression profiling. Curr. Opin. Hematol. 9:2002;333-338
5. Golub T.R., Slonim D.K., Tamayo P., Huard C., Gaasenbeek M., Mesirov J.P., et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 286:1999;531-537
6. Armstrong S.A., Hsieh J.J.-D., Korsmeyer S.J. Genomic approaches to the pathogenesis and treatment of acute lymphoblastic leukemias. Curr. Opin. Hematol. 9:2002;339-434
7. Metcalf D. Control of granulocytes and macrophages: molecular, cellular and clinical aspects. Science. 254:1991;529-533
8. Selvakumaran M., Lin H.K., TjinThamSjin R., Reed J.C., Liebermann D.A., Hoffman B. The novel primary response gene MyD118 and the proto-oncogenes myb. Mol. Cell Biol. 14:1994;2352-2360
9. McKenna S.L., Cotter T.G. Functional aspects of apoptosis in hematopoiesis and consequences of failure. Adv. Cancer Res. 71:1997;121-164
10. Hoffman B., Amanullah A., Shafarenko M., Liebermann D. The proto-oncogene c-myc in hematopoietic development and leukemogenesis. Oncogene. 21:2002;3414-3421
11. Boxer L.M., Dang C.V. Translocations involving c-myc and c-myc function. Oncogene. 20:2001;5595-5610
12. Adams J.M., Harris A.W., Strasser A., Ogilvy S., Cory S. Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector. Oncogene. 18:1999;5268-5277
13. Nesbit C.E., Tersak J.M., Prochownik E.V. MYC oncogenes in human neoplastic disease. Oncogene. 18:1999;3004-3016
14. Hoffman B., Liebermann D.A. The proto-oncogene c-myc and apoptosis. Oncogene. 17:1998;3351-3357
15. Amanullah, Liebermann DA, Hoffman B. p53-independent apoptosis associated with c-myc-mediated block in myeloid cell differentiation. Oncogene 2000;19:2967-77.
16. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 33:2001;637-668
17. Schäfer B.W., Heizmann C.W. The S100 of EF-hand calcium-binding proteins: functions and pathology. Trends. Biochem. Sci. 21:1996;134-140
18. + human monocytes. Int. Immunol. 12:2000;1593-1604
19. Yiu S., Mikami M., Yamazaki M. Purification of the cytotoxic factor in rat peritoneal exudate: its identification as the calcium binding protein complex, calprotectin. J. Leukoc. Biol. 58:1995;307-316
20. Steinbakk M., Naess-Andresen C.F., Lingaas E., Dale I., Brandtzaeg P., Fagerhol M.K. Antimicrobial actions of calcium binding leukocyte L1 protein, calprotectin. Lancet. 226:1990;763-765
21. Aguiar-Passetti T., Postol E., Sorg C., Mariano M. Epithelioid cells from foreign-body granuloma selectively express the calcium-binding protein MRP-14, a novel down-regulatory molecule of macrophage activation. J. Leukoc. Biol. 62:1997;852-858
22. Brun J.G., Ulvestad E., Fagerhol M.K., Jonsson R. Effects of human calprotectin (L1) on in vitro immunoglobulin synthesis. Scand. J. Immunol. 40:1994;675-680
23. Kerkhoff C., Klempt M., Kaever V., Sorg C. The two calcium-binding proteins S100A8 and S100A9, are involved in the metabolism of arachidonic acid in human neutrophils. J. Biol. Chem. 274:1999;32672-32679
24. Lagasse E., Clere R.G. Cloning and expression of two human genes encoding calcium-binding proteins that are regulated during myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues. Mol. Cell. Biol. 8:1988;2402-2410
25. Zwadlo G., Brüggen J., Gerhards G., Schlegel R., Sorg C. Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues. Clin. Exp. Immunol. 72:1988;510-515
26. 2+-binding proteins of neutrophils and monocytes. J. Leukoc. Biol. 53:1993;197-204
27. Koike T., Kondo K., Makita T., Kajiyama K., Yoshida T., Morikawa M. Intracellular localization of migration-inhibitory factor-related protein (MRP) and detection of cell surface MRP binding sites on human leukemia cell lines. J. Biochem. 123:1998;1079-1087
28. 2-integrin Mac-1 on human neutrophils. J. Immunol. 160:1998;1427-1435
29. Husson H., Carideo E.G., Neuberg D., Schultze J., Munoz O., Marks P.W., et al. Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays. Blood. 99:2002;282-289
30. Robinson M.J., Tessier P., Poulsom R., Hogg N. The S100 family heterodimer, MRP-8/14, binds with high affinity to heparin and heparan sulfate glycosaminoglycans on endothelial cells. J. Biol. Chem. 277(5):2002;3658-3665
31. Reeves R. Molecular biology of HMGA proteins: hubs of nuclear function. Gene. 277:2001;63-81
32. Fedele M., Pierantoni G.M., Berlingieri M.T., Battisa S., Baldassarre G., Munshi N., et al. Overexpression of protein HMGA1 induces cell cycle deregulation and apoptosis in normal rat thyroid cells. Cancer Res. 61:2001;4583-4590
33. Giancotti V., Buratti E., Perissin L., Zorzet S., Balmain A., Portella G., et al. Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures. Exp. Cell Res. 184:1989;538-545
34. Giancotti V., Bandiera A., Fusco A., Marzari R., Coles B., Goodwin G.H., et al. Comparison of multiple forms of high-mobility-group-proteins in rodent and human cells. Identification of the human high mobility group I-C protein. Eur. J. Biochem. 198:1991;211-216
35. Reeves R., Beckerbauer L. HMGI/Y proteins: flexible regulators of transcription and chromatin structure. Biochim. Biophys. Acta. 1519:2001;13-29
36. Wood L.J., Mukerjee M., Dolde C.E., Xu Y., Maher J.F., Bunton T.E., et al. HMG-I/Y, a new c-Myc target gene and potential oncogene. Mol. Cell. Biol. 15(20):2000;5490-5502
37. Segade F., Gómez-Márquez J. Molecules in focus: prothymosin α Int. J. Biochem. Cell Biol. 31:1999;1243-1248
38. Smith M.R. Prothymosin α: in search of a function. Leuk. Lymph. 18:1995;209-214
39. Eschenfeldt W.H., Berger S.L. The human prothymosin α gene is polymorphic and induced upon growth stimulation: evidence using a cloned cDNA. Proc. Natl. Acad. Sci. U.S.A. 83:1986;9403-9407
40. Wu C.L., Shiau A.-L., Lin C.-S. Prothymosin α promotes cell proliferation in NIH3T3 cells. Life Sci. 61:1997;2091-2101
41. Rodríguez P., Viñuela J.E., Alvarez-Fernández L., Bucela M., Vidal A., Dominguez F., et al. Over-expression of prothymosin α accelerates proliferation and retards differentiation in HL-60 cells. Biochem. J. 331:1998;753-761
42. Ben-Yosef T., Yanuka O., Halle D., Benvenisty N. Involvement of Myc targets in c-myc and N-myc induced human tumors. Oncogene. 16:1998;165-171
43. Eilers M., Scirm S., Bishop J.M. The myc protein activates transcription of α-prothymosin gene. EMBO J. 10:1991;133-141
44. Heldin C.-H., Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Phys. Rev. 79(4):1999;1283-1316
45. Foss B., Ulvestad E., Bruserud O. Platelet-derived growth factor (PDGF) in human acute myelogenous leukemia: PDGF receptor expression, endogenous PDGF release and responsiveness to exogenous PDGF isoforms by in vitro cultured acute myelogenous leukemia blasts. Eur. J. Haematol. 67(4):2001;267-278
46. Duhrsen U., Martinez T., Vohwinkel G., Ergun S., Sun L., McMahon G., et al. Effects of vascular endothelial and platelet-derived growth factor receptor inhibitors on long-term cultures from normal human bone marrow. Growth Factors. 19(1):2001;1-17
47. Akgul C., Moulding D.A., Edwards S.W. Molecular control of neutrophil apoptosis. FEBS Lett. 487:2001;318-322
48. Nolan B., Duffy A., Paquin L., De M., Collette H., Graziano C.M., et al. Mitogen-activated protein kinases signal inhibition of apoptosis in lipopolysaccharide-stimulated neutrophils. Surgery. 126:1999;406-412
49. Suzuki K., Hino M., Hato F., Tatsumi N., Kitagawa S. Cytokine-specific activation of distinct mitogen-activated protein kinase subtype cascades in human neutrophils stimulated by granulocyte colony-stimulating factor. Blood. 93:1999;341-349
50. Moulding D.A., Quayle J.A., Hart C.A., Edwards S.W. Mcl-1 expression in human neutrophils: regulation by cytokines and correlation with cell survival. Blood. 92:1998;2495-2502
51. Whalen R., Boyer T.D. Human glutathione-S-transferases. Semin. Liver Dis. 18(4):1998;345-358
52. Dirven H.M., van Ommen B., van Bladeren P.J. Involvement of human glutathione-S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione. Cancer Res. 54(23):1994;6215-6220
53. Salinas A.E., Wong M.G. Glutathione-S-transferases - a review. Curr. Med. Chem. 6(4):1999;279-309
54. Strange R.C., Spiteri M.A., Ramachandran S., Fryer A.A. Glutathione-S-transferase family of enzymes. Mutat. Res. 482:2001;21-26
55. Tew K.D. The influence of GST-targeted drugs on cell proliferation and stress response. Chem. Biol. Interact. 133:2001;295-300
56. Drexler HG. The leukemia-lymphoma cell line facts book. 7th ed. New York: Academic Press; 1999. p. 523.